StonvexLoading…
StonvexStonvexStonvexCore line items from PLAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-01 | Annual 2025 2025-10-31 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|
Revenue | $225.07M | $849.29M | $633.52M | $423.13M |
Operating Income | $54.86M | $208.16M | $156.05M | $107.89M |
Net Income | $42.94M | $136.41M | $74.60M | $51.71M |
EPS (Diluted) | $0.74 | $2.28 | $1.23 | $0.84 |
Total Assets | $1.90B | $1.80B | $1.75B | $1.70B |
Total Liabilities | $251.50M | $207.23M | $214.76M | $206.26M |
Cash & Equivalents | $544.13M | $492.26M | $479.52M | $530.71M |
Free Cash Flow OCF − CapEx | $49.62M | $59.66M | $39.39M | $14.17M |
Shares Outstanding | 58.11M | 57.63M | 57.59M | 58.71M |